Back to search
FDAFDA · Food and drugs·Recall number D-0384-2026

Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.

Published March 11, 2026 · Recall initiated: March 3, 2026

Summary

FDA records drug Class II recall D-0384-2026, published March 11, 2026 and initiated March 3, 2026. Recalling firm: Rising Pharma Holding, Inc.; Status: Ongoing; Reported quantity: 1200 bottles; Lot: Lot #: 1TM0524003A, Exp. Date 09/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

What to do

Voluntary: Firm initiated · Letter

Get an email if TEMOZOLOMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TEMOZOLOMIDE
Manufacturer
Rising Pharma Holding, Inc.
Distributor
Nationwide within the U.S
Lot
Lot #: 1TM0524003A, Exp. Date 09/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51. recalled?

Yes. FDA published recall D-0384-2026 on March 11, 2026. Reported hazard: Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TEMOZOLOMIDE.